Peer-reviewedCC BYFrontiers in oncology
Multicenter validation of an explainable machine-learning model for APL, AMoL, and ALL
4 affiliations
- 1Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University , , ,
- 2Department of Clinical Laboratory, The Affiliated Guangdong Second Provincial General Hospital of Jinan University , , ,
- 3Department of Clinical Laboratory, Tongling People’s Hospital , , ,
- 4Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital , , ,
Related
- Explainable machine learning integrating CT-derived intratumoral heterogeneity for histological subtype prediction in pure ground-glass lung adenocarcinoma: multicenter validation and transcriptomic characterization
- Ultrasound-based deep learning radiomics with explainable machine learning for predicting benign and malignant thyroid nodules in lymphocytic thyroiditis: a multicenter study
- Development and validation of an explainable machine learning-based risk prediction model for macrosomia in han Chinese women with singleton cephalic pregnancies
- Explainable machine learning framework with Granger-based temporal predictive validation for monitoring fiscal risk in national health insurance expenditure
- HMOX2-driven crosstalk between vascular aging and heart failure: A multimodal bioinformatics and explainable machine learning approach with experimental validation
BibTeX
@article{wang2026multicenter,
title = {{Multicenter validation of an explainable machine-learning model for APL, AMoL, and ALL}},
author = {Xuanxuan Wang and Lixiang Ma and Zhongxin Wang and Wei Huang and Mengyu Zhang and Yuanyuan Hu},
journal = {Frontiers in oncology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13657969},
note = {CC BY},
}
RIS
TY - JOUR
TI - Multicenter validation of an explainable machine-learning model for APL, AMoL, and ALL
AU - Xuanxuan Wang
AU - Lixiang Ma
AU - Zhongxin Wang
AU - Wei Huang
AU - Mengyu Zhang
AU - Yuanyuan Hu
PY - 2026
DA - 2026/10/16
JO - Frontiers in oncology
UR - https://europepmc.org/article/PMC/PMC13657969
SN - 2234-943X
ER -